Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress

Go back to Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress
(NASDAQ: LTRN) Delayed: 3.95 --0 (-0%)
Previous Close $3.95    52 Week High
Open $3.95    52 Week Low
Day High $3.95    P/E N/A 
Day Low $3.95    EPS
Volume 108